Occurrence of characteristic transient changes in WBC counts and fibrinogen values in beagle dogs subjected to single-dose toxicity studies was pointed out in the previous survey (Hoshiya et al., 2001) . These changes were thought to belong to the category of "Acute Phase Response (APR)". The purpose of the present study is to compare the APR found in the single-dose toxicity studies surveyed in our previous report with those experimentally produced by intravenous injection of 1 g/kg endotoxin (Experiment 1), and surgical treatment (Experiment 2) (intravenous indwelling catheterization). The animals used in Experiment 2 were intravenously injected with 1 g/kg endotoxin 2 weeks after the operation (Experiment 3), and the results were compared with those of Experiments 1 and 2. Each experimental group consisted of 5 dogs, and clinical, hematological and blood chemical examinations were performed.
INTRODUCTION
Occurrence of characteristic transient changes in WBC count and fibrinogen value in beagle dogs subjected to single-dose toxicity studies was pointed out in the previous survey (Hoshiya et al., 2001) . These changes were thought to belong to the category of APR. The purpose of the present study is to compare the APR found in the single-dose toxicity studies surveyed in our previous report (Hoshiya et al., 2001 ) with those experimentally produced in beagle dogs.
For this purpose, we intravenously injected endotoxin to one group of beagle dogs to produce a prototype model of APR, and the other group was subjected to surgical operation, which is also known to produce APR.
MATERIALS AND METHODS

Experimental group
The present study consisted of 3 experiments. Experiment 1: 1 g/kg endotoxin (E. coli, 055:B5) was intravenously injected.
Experiment 2: surgical operation for indwelling catheterization into the vena cava posterior was performed. Experiment 3:
animals used in Experiment 2 were subjected to intravenous injection with 1 g/kg endotoxin 2 weeks after the operation.
Animals 5 Beagle dogs (2 males and 3 females) 1 to 2 years of age were used per experimental group. The animals were individually housed in stainless cages in an animal room under controlled conditions (temperature: 18 to 25 , humidity 30 to 80%, air ventilation at 13 to 15 times per hr, lighting: 12 hr illumination per day), and fed a pelleted diet (DS-5, Oriental Yeast Co., Ltd.) and tap water ad libitum.
Surgical operation
The animals were operated on for intravenous indwelling catheterization under anesthesia by pentobarbital sodium solution. A tip of a catheter (Anthron R R 6Fr, Toray Industries, Inc.) was inserted into the posterior vena cava via the femoral vein. The other end of the catheter, after running through subcutaneous tissue, was fixed at the dorsal neck. A 24-hr continuous infusion was made using physiological saline.
Examination
Clinical observation; observation of general condition including measurement of rectal temperature and heart rate.
Laboratory examination
Total white blood cell count (Coulter Counter, T890), fibrinogen (thromboplastin method, automatic coagulometer ACL 100), differential leukocyte count (microscopic examination/May-Giemsa preparation), and erythrocyte sedimentation rate (ESR, Westergren method).
Time points of examination
On Day -1 (pretreatment), 0.5, 1, 2, 3, 4, 5 and 6 hr (Day 0) after treatment, and on Days 1, 2, 5 and 7. No examination was done for experimental group 2 from 0.5 to 6 hr after treatment to avoid the effect of general anesthesia. Differential leukocyte count and examination for erythrocyte sedimentation rate were conducted on Day -1 and from Day 1 for all groups.
Evaluation of data
Data on heart rate, rectal temperature, differential leukocyte count and erythrocyte sedimentation rate were expressed as actual values, and fibrinogen values and WBC counts were expressed as actual values and percentile changes from those on Day -1. All data were then evaluated on an individual basis by comparison with baseline data on Day -1. The data were expressed as the range in respective groups and group mean S.D. in the tables.
RESULTS
General condition 1. Experiments 1 and 3
The first sign was vomiting of foamy material and ingesta, which occurred 30 min posttreatment with endotoxin. The vomiting was followed by a decrease in spontaneous movement, and paleness and/or flushing of the conjunctival and oral mucosa. The animals took a crouching position and exhibited shivering from 1 to 2 hr posttreatment. Then excretion of soft and mucous feces was observed from 3 to 4 hr posttreatment. These various signs were conspicuous during 2 to 4 hr posttreatment and disappeared leaving a decrease in spontaneous movement and a crouching position at 5 to 6 hr posttreatment. In the next morning (morning on Day 1) all the animals had recovered from all signs. Regarding the extent of the above-mentioned signs, the animals in Experiment 3 exhibited more marked changes without exception than those in Experiment 1, and 3 out of the 5 animals took a prone position and 1 of 5 excreted vomitus and soft feces containing bloody material.
Experiment 2
Because of the effect of general anesthesia, no recording was made on general condition up to 6 hr posttreatment. In the next morning (morning on Day 1) all the animals exhibited normal appearance.
Rectal temperature 1. Experiments 1 and 3
As shown in Table 1 , rectal temperature rose to the maximum 39.6 (Experiment 1, group mean) or 40.5 (Experiment 3, group mean) at the peak time of 3 hr posttreatment during 1 to 5 or 6 hr postinjection. The fever went down in 4 out of the 5 animals at 5 hr postinjection in Experiment 1 and in 2 out of the 5 animals at 6 hr postinjection in Experiment 3. The change in rectal temperature was recorded about 1 hr after the shivering in many animals.
From Day 1 on, there were no changes in rectal temperature in any experimental group.
Heart rate 1. Experiments 1 and 3
As shown in Table 2 , fluctuations in heart rate were recorded up to 5 hr postinjection in both experimental groups and the change was marked in all of the animals in Experiment 3 (background range in male beagle dogs 7 months of age: 122 24 beat/min). There were marked individual difference in the changes. The individual changes, increase and decrease, ranged 17 to 52% in Experiment 1 and 34 to 75% in Experiment 3 versus the baseline values on Day 1. The heart rate tended to increase in some individuals in Experiment 3, with the maximum increase of 75% versus the baseline value, and tended to decrease in all individuals in Experiment 1, with the maximum decrease of 52% versus the baseline value.
WBC count
Data are shown in Table 3 . 2001  116  140  160  152  192  192  176  144  2002  140  104  108  120  92  112  104  120  2003  120  80  100  112  96  108  100  96  2004  136  100  124  140  148  152  124  120  2005  80  132  116  140  104  120  112  104 Unit: beat per min, with no group mean calculated because of the large intragroup difference.
1. Experiments 1 and 3, from 0.5 hr to 6 hr postinjection on Day 0 Marked decreases in the WBC count were recorded in the examinations at 0.5 to 1 hr postinjection in both experiments. The change was marked in the animals in Experiment 3 and the minimum value versus the baseline values reached 15 to 21% at 30 min and 23 to 37% at 1 hr postinjection in Experiment 1. Then, the counts gradually increased and reached or exceeded the baseline levels at 6 hr postinjection.
Experiments 1, 2 and 3, from Day 1 to Day 7
The count was maximum on Day 1 and Day 2 in all groups. The group mean maximum values versus the baseline values on Day 1 were 212% (range: 187 to 247%), 210% (166 to 259%) or 235% (127 to 293%) in Experiments 1, 2 and 3 respectively. On Day 5, the counts were close to the baseline values in Experiments 1 and 3. The rate of decrease was rather slow in Experiment 2.
Differential WBC count
Data are shown in 
Fibrinogen Value
Data are shown in Table 5 . 1. Experiments 1 and 3, from 0.5 hr to 6 hr postinjection on Day 0
Decreased fibrinogen values were recorded up to 6 hr postinjection with the lowest value of about 30% decrease at 1 to 3 hr postinjection in both groups. The values were close to the baseline values at 6 hr postinjection.
Experiments 1, 2 and 3, from Day 1 to Day 7
The value was the maximum on Day 1 in Experiments 1 and 3, and on Day 2 posttreatment in Experiment 2. The group mean maximum values versus the baseline values on Day 1 were 169 % (range: 141 to 210%), 186% (147 to 225%) or 202 % (143 to 223%) in Experiments 1, 2 and 3, respectively. On Day 5, the values were close to the baseline values in all groups.
Erythrocyte sedimentation rate
As shown in Table 6 , erythrocyte sedimentation rate rose on Day 1 (the day following injection with endotoxin) in Experiments 1 and 3, or on Day 2 in Experiment 2. Increased erythrocyte sedimentation rate recorded on Day 1 and Day 2 in all groups mostly coincided with the increase in fibrinogen except in a few cases, but in contrast increased erythrocyte sedimentation rate on Day 5 and Day 7 in all groups occurred independently of changes in fibrinogen.
DISCUSSION
The present experimental study revealed that essentially the same changes in WBC counts and fibrinogen values were provoked by intravenous injection with endotoxin and by surgical operation. In the present study, sequential observation during 6 hr immediately after the operation could not be carried out because of the effect of general anesthesia. The most remarkable changes common to both treatments were transient increases in the WBC count and fibrinogen value during the 2 days from Day 1 to Day 2 of the treatment. The predominant cells in these changes of WBC count were neutrophils. These changes were preceded by decreasing fibrinogen values and leukopenia in animals injected with endotoxin. In the present study, the response to intravenous injection with endotoxin, especially the clinical abnormality seen in animals in Experiment 3, was more severe than in animals in Experiment 1. The reasons giving rise to the inequality in the response remain unexplained. In both experiments, the only difference was the previous surgical operation in Experiment 3.
Smaller amounts of endotoxin have been known to produce fever, altered resistance to bacterial infection, leukopenia followed by leukocytosis, and numerous other biological effects (Anderson, 2000) . Fever, leukocytosis, acute phase response and increased erythrocyte sedimentation rate are important clinicopathological signs, which occur within 1 day of any injurious effect (Majno and Joris, 1996) . Because fibrinogen is one of the positive acute phase proteins, the erythrocyte sedimentation rate reflects APR (Gregus and Klaassen, 108 Vol. 26 No. 2 1996; Majno and Joris, 1996) . Regardless of the initiating event, the macrophage or monocyte is usually the cell that elicits the acute phase cascade (Baumann and Gauldie, 1994) . Any substance capable of appropriately triggering macrophages may therefore cause an APR even if it has no other action or toxicity (Pepys and Baltz, 1983) . From the above-mentioned point of view, it is natural that the surgical operation for intravenous indwelling catheterization caused APR in the animals. The necessity of various animal models which require surgical operation as employed in the present study is steadily increasing year by year in the field of practical toxicity studies. In the previous paper, the authors reported that about 1/2 of the single-dose toxicity studies surveyed exhibited characteristic changes which seemed to belong to the category of acute phase response (Hoshiya et al., 2001) . Therefore it seems the acute phase response will become more common in many laboratories.
In conclusion, the present study revealed that such surgical operations as intravenous indwelling catheterization produced changes typical of APR similar to those produced by intravenous injection with endotoxin in beagle dogs. The changes observed were also similar to those previously reported in findings seen in beagle dogs subjected to xenobiotic exposure (Hoshiya et al., 2001) . Thus the biological significance of APR as a non-specific defense mechanism was confirmed in various events in beagle dogs.
